{"id":31243,"date":"2014-09-16T08:56:31","date_gmt":"2014-09-16T12:56:31","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=31243"},"modified":"2014-09-16T08:56:31","modified_gmt":"2014-09-16T12:56:31","slug":"astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243","title":{"rendered":"AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer&#8217;s Drug"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/16\/2014 (wallstreetpr) \u2013 According to reports, <strong>AstraZeneca plc (ADR) (NYSE:AZN)<\/strong> has decided to enter into a partnership with <strong>Eli Lilly and Co (NYSE:LLY)<\/strong> in order to ensure a smooth development of Alzheimer&#8217;s drug. The deal will cost around $500 million to AZN. As per the information, British Group had decided to come up with an experimental drug of Alzheimer&#8217;s drug sometime back. Currently, the drug is in the Phase II development and soon it will enter in the late-stage Phase III development.<\/p>\n<p style=\"text-align: justify;\"><strong>Road so far:<\/strong><\/p>\n<p style=\"text-align: justify;\">AstraZeneca plc (ADR) (NYSE:AZN) made an announcement couple of month\u2019s back that it was looking for a partner for the development of its well-acclaimed BACE inhibitor drug, AZD3293. The company made a significant progress in less than three month&#8217;s time and closed the deal successfully.<\/p>\n<p style=\"text-align: justify;\"><strong>Terms and conditions of the deal: <\/strong><\/p>\n<p style=\"text-align: justify;\">AZN has entered struck a partnership deal Eli Lilly and Co (NYSE:LLY) in which the latter one will pay close to $500 million to AstraZeneca plc (ADR) (NYSE:AZN), depending upon the progress of the development process of the drug. On the question of receiving payment, one of the spokesmen of AZN said that the company was expecting the first installment of the total payment of $50 million by the first half of 2015. The announcement was made on Tuesday morning.<\/p>\n<p style=\"text-align: justify;\">When it comes to the cost of production, the management of AstraZeneca plc (ADR) (NYSE:AZN) has clarified that both the firms will share the total production cost of Alzheimer&#8217;s drug named AZD3293 equally. At the same time, the revenue generated over a period in the future will also be shared by both the companies in the same proportion in which cost will be distributed. Healthcare industry is going through one of the good phases in the long run where companies are putting more efforts towards research than cost cutting. No individual from both the companies was available to share his views after the announcement.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/16\/2014 (wallstreetpr) \u2013 According to reports, AstraZeneca plc (ADR) (NYSE:AZN) has decided to enter into a partnership with Eli Lilly and Co (NYSE:LLY) [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":20478,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[7028,4503,7031,5208,4504,1769],"stock_ticker":[],"class_list":["post-31243","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-astrazeneca-plc-adr","tag-astrazeneca-plc-adr-nyseazn","tag-eli-lilly-and-co","tag-eli-lilly-and-co-nyselly","tag-nyseazn","tag-nyselly","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer&#039;s Drug - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer&#039;s Drug - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/16\/2014 (wallstreetpr) \u2013 According to reports, AstraZeneca plc (ADR) (NYSE:AZN) has decided to enter into a partnership with Eli Lilly and Co (NYSE:LLY) [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-16T12:56:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"381\" \/>\n\t<meta property=\"og:image:height\" content=\"132\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer&#8217;s Drug\",\"datePublished\":\"2014-09-16T12:56:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243\"},\"wordCount\":342,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg\",\"keywords\":[\"AstraZeneca plc (ADR)\",\"Astrazeneca Plc (ADR) (NYSE:AZN)\",\"Eli Lilly and Co\",\"Eli Lilly and Co (NYSE:LLY)\",\"NYSE:AZN\",\"NYSE:LLY\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243\",\"name\":\"AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer's Drug - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg\",\"datePublished\":\"2014-09-16T12:56:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg\",\"width\":381,\"height\":132},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer&#8217;s Drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer's Drug - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243","og_locale":"en_US","og_type":"article","og_title":"AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer's Drug - Wall Street PR","og_description":"Boston, MA 09\/16\/2014 (wallstreetpr) \u2013 According to reports, AstraZeneca plc (ADR) (NYSE:AZN) has decided to enter into a partnership with Eli Lilly and Co (NYSE:LLY) [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-16T12:56:31+00:00","og_image":[{"width":381,"height":132,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer&#8217;s Drug","datePublished":"2014-09-16T12:56:31+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243"},"wordCount":342,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg","keywords":["AstraZeneca plc (ADR)","Astrazeneca Plc (ADR) (NYSE:AZN)","Eli Lilly and Co","Eli Lilly and Co (NYSE:LLY)","NYSE:AZN","NYSE:LLY"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243","url":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243","name":"AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer's Drug - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg","datePublished":"2014-09-16T12:56:31+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg","width":381,"height":132},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-to-enter-into-partnership-with-eli-lilly-and-co-nyselly-on-alzheimers-drug-31243#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer&#8217;s Drug"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=31243"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31243\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/20478"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=31243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=31243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=31243"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=31243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}